59779-571-31 : NDC 2026 Code

59779-571-31 : Acetaminophen, Aspirin, Caffeine ( Headache Relief )

Additionally :

You can get information about “59779-571-31” NDC code in 59779-571-31 in HTML format

HTML | 59779-571-31 in TXT (Plain Text) format

TXT | 59779-571-31 in PDF (Portable Document Format)

PDF | 59779-571-31 in XML format

XML formats.

NDC Code : 59779-571-31 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "59779-571-31",
    "PackageDescription": "1 BOTTLE in 1 CARTON (59779-571-31)  &gt; 80 TABLET in 1 BOTTLE",
    "NDC11Code": "59779-0571-31",
    "ProductNDC": "59779-571",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Headache Relief",
    "ProprietaryNameSuffix": "Extra Strength",
    "NonProprietaryName": "Acetaminophen, Aspirin, Caffeine",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20090109",
    "EndMarketingDate": "20220318",
    "MarketingCategoryName": "OTC MONOGRAPH NOT FINAL",
    "ApplicationNumber": "part343",
    "LabelerName": "CVS Pharmacy",
    "SubstanceName": "ACETAMINOPHEN; ASPIRIN; CAFFEINE",
    "StrengthNumber": "250; 250; 65",
    "StrengthUnit": "mg/1; mg/1; mg/1",
    "Pharm_Classes": "Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2022-03-19",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20090109",
    "EndMarketingDatePackage": "20220318",
    "SamplePackage": "N"
  }
}